Skip to main content
Clinical Trials/NCT02851186
NCT02851186
Completed
Not Applicable

Combined Electroacupuncture and Auricular Acupuncture for Postoperative Pain After Abdominal Surgery for Gynecological Diseases: A Randomized Sham-controlled Trial

The University of Hong Kong2 sites in 1 country72 target enrollmentOctober 12, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
The University of Hong Kong
Enrollment
72
Locations
2
Primary Endpoint
Area under the curve of Pain intensity by numerical rating scale (NRS) from baseline to day 5
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Objectives:

To examine the efficacy and safety of electroacupuncture (EA) combined with auricular acupuncture (AA) in reducing post-operative pain in patients following abdominal surgery for gynecological diseases.

Hypothesis:

Acupuncture is effective and safe to reduce postoperative pain during the first 5 days following surgery as compared to a sham control.

Design and strategy:

This is a randomized, placebo-controlled, subject- and assessor-blind trial. Seventy-two subjects will be recruited and randomized (in 1:1 ratio) to receive either acupuncture treatment or sham control. Subjects in both groups will undergo standard operation procedure and receive post-operative analgesics based on usual care.

Study instrument:

A 10-point pain Numerical Rating Scale (NRS) will be employed as a primary outcome assessment.

Intervention:

Subjects in the treatment group will receive EA combined with AA within two hours before operation, post-operation upon arrival to the ward and once a day for the subsequent 5 days. Subjects in the control group will receive non-invasive sham procedure in the same schedule.

Main outcome measures:

Primary outcome: NRS pain scores will be measured upon recovery, hourly at 6 hours after surgery, then 4-hourly until day 2, 6-hourly until day 3 and once daily until discharge.

Secondary outcome:

Morphine consumption, post-operative syndromes, quality of recovery questionnaire, SF-6D, EQ-5D-5L and adverse events will be documented and compared between groups.

Data analysis: Pain intensity during the first 5 days will be calculated by Area Under the Curve (AUC) of NRS pain scores. AUC between the two groups will be compared by Student's T-test.

Expected outcome: AUC of the acupuncture group is expected to be significantly lower than sham acupuncture group.

Registry
clinicaltrials.gov
Start Date
October 12, 2016
End Date
November 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) physical status I to III
  • Eligible for laparotomy with midline incision for gynaecological neoplasm including ovarian mass, uterine mass and cervical lesions
  • Age 18 years or above
  • Ability to understand the nature of the study and willing to give informed consent
  • Capable of providing responses during outcome measurement

Exclusion Criteria

  • Having chronic pain and using any medication in addition to the anaesthetic and analgesia prescribed prior to surgery that would be expected to affect the dosage of postoperative analgesia
  • History of or current alcohol or drug abuse
  • Impaired renal function, defined as preoperative serum creatinine level over 120µmol/L
  • Impaired hepatic function, defined as preoperative serum albumin level below 30g/L
  • Impaired or retarded mental state and not able to sign the consent
  • Not self-ambulatory before operation
  • Difficulties in using patient-controlled analgesia
  • BMI \> 35kg/m2
  • Infection observed at the acupoint sites
  • History of acupuncture experience in the previous 12 months

Outcomes

Primary Outcomes

Area under the curve of Pain intensity by numerical rating scale (NRS) from baseline to day 5

Time Frame: 5 days

Secondary Outcomes

  • Time of recovery from postoperative syndrome(Through study completion, an average of 7 days)
  • Quality of recovery (QoR-9)(Through study completion, an average of 7 days)
  • Pain intensity by numerical rating scale (NRS) at rest(Through study completion, an average of 7 days)
  • Pain intensity by numerical rating scale (NRS) while coughing(Through study completion, an average of 7 days)
  • Cumulative morphine consumption(Through study completion, an average of 7 days)
  • Dose of rescues analgesic (IM morphine) use(Through study completion, an average of 7 days)
  • Frequency of rescues analgesic (IM morphine) use(Through study completion, an average of 7 days)
  • SF-6D(Through study completion, an average of 7 days)
  • EQ-5D-5L(Through study completion, an average of 7 days)

Study Sites (2)

Loading locations...

Similar Trials